WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 2-Jul-2015 (Data received as of 26-June-2015)
Next overall update Mid July 2015
2014 data are provisional
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 2701 Infant (under 12 months) mortality rate: 462
GDP / capita (US$): 7801 Child (under 5 years) mortality rate: 712

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 16'829  16'363  15'906  15'458  15'014  11'321  9'447  6'237 
Births 665  652  639  626  614  512  455  339 
Surviving infants 609  596  583  571  558  454  392  287 
Pop. less than 5 years 2'880  2'870  2'859  2'819  2'730  2'047  1'708  1'244 
Pop. less than 15 years 7'576  7'410  7'249  7'076  6'878  5'187  4'326  2'938 
Female 15-49 years 3'799  3'672  3'549  3'435  3'334  2'552  2'216  1'435 

Number of reported case

(Click for retrospective incidence data for Malawi)
Diphtheria 13 
Japanese encephalitis
Measles 11  26  118'712  304  162'686 
Mumps
Pertussis 365  29'769 
Polio* 70 
Rubella 433  23  56  267  28 
Rubella (CRS)
Tetanus (neonatal) 12  211  163 
Tetanus (total)** 12  461 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Malawi)
Vaccine year result method % card seen                                                
BCG 2009  97  DHS   81  97  96  99  99  97  83  84  99 
DTP1 2009  97  DHS   81  97  96  99  98  97  98 
DTP3 2009  93  DHS   81  91  89  96  97  93  75  80  58 
HepB_BD         
HepB3 2009  93  DHS   81  91  89  96  97  93 
Hib3 2009  93  DHS   81  91  89  96  97  93 
JapEnc         
MCV          85  88  90  96  93  73  81  49 
MCV2         
PCV1          96  96  99  39 
PCV3          87  89  99 
Pol3 2009  86  DHS   81  87  89  95  97  86  73  93  28 
Rota1          89  87  19 
Rota_last          60  81 
Rubella1         
TT2plus 1994  77  MICS   88  90  65  71  79  89  61  76 
PAB         
VAD1          28  32  61  25  40  75 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Malawi)
BCG 96  99  99  97  83  97 
DTP1 96  99  98  97  98  95  80 
DTP3 89  96  97  93  75  87  58 
HepB3 89  96  97  93 
HepB_BD
Hib3 89  96  97  93 
MCV 88  90  96  93  73  81  49 
MCV2
PAB 89  89  87  87  84  81 
PCV3 89  99 
Pol3 89  95  97  86  73  93  28 
Rota_last 81 

Number of districts in the country 28  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 43
From 80 to 89% 46
From 50 to 79% 11
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 1st contact; +2, +4 months; No girls aged 9-13 years
Measles 9 months; Yes
OPV 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
TT 1st contact; +1, +6 months; +1, +1 year; Yes pregnant women and CBAW
VitaminA 6, 12, 18, 24, 30, 36 months; Yes and postpartum

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2012-2016  2012-2016  2012-2016  2010-2014  2010-2014  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 28  28  28  28  28  28  26 

System performance

Total Nº districts in country number 28  28  28  28  28  28  26 
Nº districts with DTP3 coverage >=80% number 25  21  26  28  28  27  25 
% of districts with DTP3 coverage >=80% From 0 to 100% 89  75  93  100  100  96  96 
Nº districts with measles (MCV1) coverage >=95% number 11  15  16 
% of districts with MCV1 coverage >=95% From 0 to 100% 32  29  39  54  57  29  19 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 10  53      32  50   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.